Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome

Area of Science:

• Ophthalmology
• Neuroscience
• Clinical Trials

Background:

• Optic neuritis can cause significant vision loss.
• Predictive markers for long-term visual outcomes are needed.
• Eligibility criteria for clinical trials in optic neuritis are crucial for testing new therapies.

Purpose of the Study:

• To identify visual measure cutpoints at baseline and 1 month that predict abnormal 6-month vision in optic neuritis patients.
• To establish eligibility criteria for clinical trials investigating neuroprotection or myelin repair agents.
• To determine the correlation between visual dysfunction and major vision loss at 6 months.

Main Methods:

• Utilized the Optic Neuritis Treatment Trial database.
• Evaluated cutpoints for visual acuity, contrast sensitivity, and visual field at baseline and 1 month.
• Calculated positive predictive values and sample sizes for trial eligibility.
• Assessed the correlation between visual dysfunction and 6-month vision outcomes.

Main Results:

• Optimal cutpoints at baseline and 1 month included visual acuity ≤ 20/50, contrast sensitivity < 1.0 log units, and visual field mean deviation ≤ -15 dB.
• Visual dysfunction at 1 month, but not baseline, significantly correlated with moderate-to-severe vision loss at 6 months (p=0.01).
• Clinical trials could require as few as 100 subjects, but 1-month cutpoints, while predictive, would limit patient eligibility.

Conclusions:

• Established visual measure cutpoints can predict long-term vision outcomes in optic neuritis.
• These findings support patient counseling and the design of clinical trials for optic neuritis therapies.
• The identified criteria can help in selecting high-risk patients for studies aimed at reducing permanent optic nerve damage.